56 results on '"Pantarotto, Jason"'
Search Results
2. Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study
3. 302 Health Care System Factors Associated with Receipt of Treatment and with Treatment Intent in Stage Iii Non-Small Cell Lung Cancer: A Population-Based Study in Ontario
4. 221 Survey on the Structure of Inpatient Care Provided by Radiation Oncologists in Canada
5. 297 Population Analysis of SABR/SRS for the Treatment of Metastatic Cancer in a Jurisdiction of 15 Million People
6. Breast Metastasis From Primary Lung Cancer and its Association with Ablative Radiotherapy: A Case Report
7. A Clinical Consensus Approach to Developing a New Funding Model for Radiation Services in Ontario
8. Pan-Canadian consensus recommendations for proton beam therapy access in Canada
9. 9: Trends in Radiotherapy Fractionation in Ontario From 2011/12 to 2020/21 for the Major Disease Sites and the Impact of COVID19
10. Developing Radiation Treatment Protocols to Support the Transition to a Quality Based Procedure
11. Cancer Clinic Redesign: Opportunities for Resource Optimization
12. Cancer clinic redesign: Opportunities for Resource Optimization
13. Cancer Clinic Redesign: Opportunities for Resource Optimization
14. 130: Radiation Oncologist Consultations Prior to Radical Prostatectomy in Ontario: Disparities and Implications for Health Human Resource Planning
15. 102: Treatment Planning During the Pandemic – Did Flexible Work Arrangements Make us More Efficient?
16. 142: Virtual Care Uptake in Radiation Medicine: Lessons Learned from the COVID-19 Pandemic
17. 149: Do Virtual Ro Consults Expedite Treatment? Another Tale from the COVID-19 Pandemic
18. 146: COVID-19 Pandemic Impact on Radiation Treatment Delivery Metrics
19. 114: Quality Assurance of Radiotherapy During the COVID-19 Pandemic: Impact on Peer Review in 14 Regional Cancer Centres Across Ontario
20. Radiation oncologist consultations prior to prostatectomy in Ontario, Canada: Disparities and opportunities.
21. Validating impact of pretreatment tumor growth rate on outcome of early‐stage lung cancer treated with stereotactic body radiation therapy
22. Adrenal oligometastasis cured with stereotactic ablative radiotherapy
23. 39: Impact of Smoking Status and Pack Year History on Outcomes of Early Stage Non-Small Cell Lung Cancers Treated with Stereotactic Ablative Radiotherapy
24. A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain Oligometastases
25. Clinical Specialist Radiation Therapist in Palliative Radiation Therapy: Report of an Orientation, Training, and Support Program
26. 25 Stereotactic Body Radiation Treatment of Synchronous Early Stage Non-Small Cell Lung Cancers
27. 113 Outcome Comparison Between Early Stage Adenocarcinoma and Squamous Cell Carcinoma Lung Cancers Treated with Stereotactic Body Radiation Therapy
28. Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non–Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial
29. Anemia is a poor prognostic factor for stage I non-small cell lung cancer (NSCLC) patients treated with Stereotactic Body Radiation Therapy (SBRT)
30. Radiation dose mapping and anastomotic complications after trimodality therapy for esophageal cancers
31. Mo1307 HOW GOOD IS EUS GUIDED FIDUCIAL PLACEMENT FOR TARGETED CYBERKNIFE RADIOTHERAPY?
32. Mo1301 NOVEL PLATINUM FIDUCIAL SEEDS MADE IN HOUSE AND WIRE PUSH DELIVERY METHOD
33. Radical Treatment of Stage II Non–small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes
34. Quantitative texture analysis on pre-treatment computed tomography predicts local recurrence in stage I non-small cell lung cancer following stereotactic radiation therapy
35. Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer
36. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial
37. Directly Improving the Quality of Radiation Treatment Through Peer Review: A Cross-sectional Analysis of Cancer Centers Across a Provincial Cancer Program
38. P1.05-069 Stage II NSCLC Treated with Non-Surgical Approaches: A Multi-Institution Report of Outcomes
39. 221: Radiation Dose Mapping of the Stomach in Trimodality Therapy for Esophageal Cancer
40. 236: Validity of Specific Growth Rate in Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy (SBRT)
41. CONVERT: An international randomised trial of concurrent chemo-radiotherapy (cCTRT) comparing twice-daily (BD) and once-daily (OD) radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status (PS).
42. Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1–3 metastases
43. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists
44. Lung cancer diagnosis transformation: Aligning the people, processes, and technology sides of the learning system.
45. Abstract 763: Implications of resistance patterns with NSCLC targeted agents
46. Phase II study of neoadjuvant irinotecan, capecitabine, oxaliplatin (IXO) followed by chemoradiotherapy (CRT) using concurrent capecitabine for resectable locally advanced rectal cancer.
47. Stage II non-small cell lung cancer treated with nonsurgical approaches.
48. Prognostic Factors in the Radical Nonsurgical Treatment of Stage IIIB Non–Small-Cell Lung Cancer
49. Upper abdominal normal organ contouring guidelines and atlas: A Radiation Therapy Oncology Group consensus
50. Pretreatment [18F]-fluoro-2-deoxy-glucose Positron Emission Tomography Maximum Standardized Uptake Value as Predictor of Distant Metastasis in Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy: Rethinking the Role of Positron Emission Tomography in Personalizing Treatment Based on Risk Status
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.